Prostate cancer is the most common cancer and the second leading cause of cancer death in men. The imaging assessment and treatment of prostate cancer has vastly improved over the past decade. The introduction of PSMA PET-CT has improved the detection of loco-regional and metastatic disease. PSMA PET-CT also has a role in the primary diagnosis and staging, in detecting biochemical recurrence after curative treatment and in metastasis-directed therapy. In this paper we review the role of PSMA PET-CT in prostate cancer
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed in the majority ...
IntroductionProstate-specific membrane antigen (PSMA) is increasingly being recognized as a novel ta...
Radiolabelled small molecules for imaging prostate cancer have rapidly emerged over the last few yea...
Positron-emission tomography (PET) with prostate-specific membrane antigen (PSMA) has been increasin...
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer (PCa) cells, a...
BACKGROUND Since their clinical introduction in 2011, PSMA-PET/CT (PSMA: prostate-specific membra...
INTRODUCTION: Prostate specific membrane antigen (PSMA) positron emission tomography (PET) with comp...
Prostate cancer imaging has become an important diagnostic modality for tumor evaluation. Prostate-s...
Introduction: Prostate specific membrane antigen (PSMA) positron emission tomography (PET) with comp...
OBJECTIVE: The purpose of this article is to describe the large number of radiotracers being evalu...
Gallium-68 and Fluor-18 labeled prostate specific membrane antigen (PSMA) molecules have created new...
Conventional imaging has been the standard imaging modality for assessing prostate cancer recurrence...
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) scans have higher sensi...
Background: prostate-specific membrane antigen (PSMA) ligand PET has been recently incorporated into...
Background Imaging plays an important role in the evaluation of prostate cancer patients. In recent ...
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed in the majority ...
IntroductionProstate-specific membrane antigen (PSMA) is increasingly being recognized as a novel ta...
Radiolabelled small molecules for imaging prostate cancer have rapidly emerged over the last few yea...
Positron-emission tomography (PET) with prostate-specific membrane antigen (PSMA) has been increasin...
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer (PCa) cells, a...
BACKGROUND Since their clinical introduction in 2011, PSMA-PET/CT (PSMA: prostate-specific membra...
INTRODUCTION: Prostate specific membrane antigen (PSMA) positron emission tomography (PET) with comp...
Prostate cancer imaging has become an important diagnostic modality for tumor evaluation. Prostate-s...
Introduction: Prostate specific membrane antigen (PSMA) positron emission tomography (PET) with comp...
OBJECTIVE: The purpose of this article is to describe the large number of radiotracers being evalu...
Gallium-68 and Fluor-18 labeled prostate specific membrane antigen (PSMA) molecules have created new...
Conventional imaging has been the standard imaging modality for assessing prostate cancer recurrence...
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) scans have higher sensi...
Background: prostate-specific membrane antigen (PSMA) ligand PET has been recently incorporated into...
Background Imaging plays an important role in the evaluation of prostate cancer patients. In recent ...
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed in the majority ...
IntroductionProstate-specific membrane antigen (PSMA) is increasingly being recognized as a novel ta...
Radiolabelled small molecules for imaging prostate cancer have rapidly emerged over the last few yea...